Issue 3: Pharma Digest
Welcome to your bi-weekly newsletter.
The industry has never been more primed to drive positive change, however post-Covid health systems are at their limit, so pharma must again evolve to take the lead. Keeping your organisation up to speed can be tricky - we're here to help solve that problem.
The Digest is for you, the valued members of our Pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.
Let's get started.
Connected HCP experiences: The holy grail of precision marketing
Pharma has a long way to go to achieve a truly tailored customer experience, down to the level of individual HCPs. Right now, they are not receiving targeted and contextually relevant information they desire.
While multichannel offerings are improving, they still exist in silos and therefore delivering disjointed experiences. Therefore, it’s crucial that pharma builds on its strengths in content by unifying data to deliver a single view of HCPs.??
Access the new article to learn about connected HCP experiences in partnership with Treasure Data.
How important are your company’s sustainability efforts, to you as an employee?
Whether it's efforts to reduce pharma's carbon footprint, corporate social responsibility or ESG-related goals, we're keen to know how important sustainability is to those working in our industry. Vote here!
This Week's Top 5 Pharma News to Watch
1. Pfizer looks past COVID with $43 bln deal for cancer drug maker Seagen (Reuters.com, March 13)
2. First major insurer covers Eisai’s Alzheimer’s drug Leqembi (pharmaphorum, March 14)
3. UK health service opens facility to develop and produce cell and gene therapies (Fierce Pharma, March 14)
(Pharmaphorum, March 14)
5. With positive combo meningococcal vaccine data, GSK eyes US approval (Reuters.com, March 14)
Reuters Events Pharma USA is taking place in less than 2 weeks. Join 1000+ of North America’s visionary pharma changemakers, leading solution providers, patient experts and industry heavyweights to catapult commercial excellence, ingrain patient-first strategies into the heart of pharma’s fabric and heed the long-awaited rebirth of America’s healthcare system.?#REpharmaUSA?
领英推荐
Secure your free VIP upgrade with ‘VIPADD’ when purchasing a business pass by 3/17 to unlock year-round content worth $15k
Reuters Events: Pharma 2023 is the place where patient experts and pharma changemakers – from commercial, marketing, medical affairs, patient engagement, market access, RWE and Digital Health – share new best-practice, lessons learned and strategies for the future. #REpharma2023
Register by Friday 17 March to save €300 – just apply the code SALE300 at checkout!
That rounds off Issue 3 of the Pharma Digest.
We'll be back in two weeks with more important news, market updates, pharma content, and updates on our events. Don’t forget to subscribe to receive a notification for our next bi-weekly digest.
If you have ideas, suggestions, or questions for the team, don't hesitate to let us know in the comments, or get in touch directly.
?
USA Team
Kana Hutton – Marketing/ Commercial
Hannah Brady – Medical Affairs
Daisy Beale – Patient/ Cell and Gene
Charlotte Bastiaanse – RWE/ Market Access
?
EU Team
Daniel Baker – Marketing/ Commercial
Joey Buchholz – Medical Affairs
Usmaan Khan – Patient
Charlotte Bastiaanse – RWE/ Market Access
?
See you next time!
Flagship events, project management and DEI
2 年Excited to read this!